Quantum Genomics Enters into Exclusive Licensing and Collaboration Agreement with Faran

Faran to receive an exclusive license to develop and commercialize firibastat for the treatment of difficult to treat/resistant hypertension in GREECE.

READ THE ORIGINAL POST AT www.globenewswire.com